首页> 外国专利> Use of nuclear receptors involved in lipid metabolism to screen substances which are useful for treating lipid metabolism dysfunctions such as hyperlipidaemia, obesity or syndrome X

Use of nuclear receptors involved in lipid metabolism to screen substances which are useful for treating lipid metabolism dysfunctions such as hyperlipidaemia, obesity or syndrome X

机译:使用参与脂质代谢的核受体来筛选可用于治疗脂质代谢功能障碍(例如高脂血症,肥胖症或综合症X)的物质

摘要

Use of Rev-erb receptors (I), and/or their response elements (II), or their functional equivalents, for screening substances (S) which are useful for treating lipid metabolism dysfunctions. Independent claims are also included for the following: (1) a process for screening (S), which involves placing a test substance (T) in contact with a Rev-erb family receptor and/or (II) and/or a nuclear receptor (III) which couples (I) to the RNA polymerase complex, or their functional equivalents, and measuring the binding of (T) to (I), or the binding of (T)-(I) complex to (II) and/or to (III), and/or measuring the modulation of the transcriptional activity of the genes placed under the control of a promoter comprising (II); and (2) a process for screening (S) which consists of determining the effect of (T) on the modulation of the expression of the gene encoding (I).
机译:Rev-erb受体(I)和/或它们的反应元件(II)或它们的功能等同物在筛选可用于治疗脂质代谢功能异常的物质(S)中的用途。还包括以下方面的独立权利要求:(1)筛选(S)的过程,该过程涉及将测试物质(T)与Rev-erb家族受体和/或(II)和/或核受体接触(III)将(I)与RNA聚合酶复合物或其功能等同物偶合,并测量(T)与(I)的结合,或(T)-(I)复合物与(II)和/的结合(III),和/或测量置于包含(II)的启动子控制下的基因的转录活性的调节; (2)筛选(S)的方法,其包括确定(T)对编码(I)的基因表达的调节的作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号